Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer (vol 13, 1011810, 2023)

被引：0
作者：
Peng, Yurong [1 ]
Li, Zhuo [2 ]
Fu, Yucheng [1 ]
Pan, Yue [1 ]
Zeng, Yue [1 ]
Liu, Junqi [1 ]
Xiao, Chaoyue [1 ]
Zhang, Yingzhe [1 ]
Su, Yahui [3 ]
Li, Guoqing [3 ]
Wu, Fang [1 ]
机构：
[1] Cent South Univ, Xiangya Hosp 2, Dept Oncol, Changsha, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Hosp 2, Ophthalmol Ctr, Changsha, Hunan, Peoples R China
[3] Cent South Univ, XiangYa Sch Publ Hlth, Changsha, Hunan, Peoples R China
来源：
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词：
perioperative period perioperative immunotherapy; neoadjuvant therapies; immunotherapy; neoadjuvant immune monotherapy; adjuvant therapy; biomarkers; NSCLC; lung cancer;
D O I：
10.3389/fonc.2023.1163376
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Combination Immunotherapy in Non-small Cell Lung Cancer
    Melina E. Marmarelis
    Charu Aggarwal
    Current Oncology Reports, 2018, 20
  • [42] Adjuvant immunotherapy for non-small cell lung cancer
    Tucker, Zachary C. G.
    Laguna, Benjamin A.
    Moon, Edmund
    Singhal, Sunil
    CANCER TREATMENT REVIEWS, 2012, 38 (06) : 650 - 661
  • [43] Combination Immunotherapy in Non-small Cell Lung Cancer
    Marmarelis, Melina E.
    Aggarwal, Charu
    CURRENT ONCOLOGY REPORTS, 2018, 20 (07)
  • [44] Clinical Approaches to Immunotherapy in Non-Small Cell Lung Cancer: Current and Future Perspectives
    Rice, Shawn J.
    Miller, Bruce
    Wagman, Matthias
    Jamorabo, Daniel S.
    Liu, Xin
    Belani, Chandra P.
    CURRENT MOLECULAR PHARMACOLOGY, 2016, 9 (03) : 183 - 195
  • [45] Biomarkers in Non-Small Cell Lung Cancer: Perspectives of Individualized Targeted Therapy
    Aoki, Mateus N.
    Amarante, Marla K.
    de Oliveira, Carlos E. C.
    Watanabe, Maria A. E.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2018, 18 (15) : 2070 - 2077
  • [46] DNA repair pathways and non-small cell lung cancer: clinical perspectives
    Olaussen, Ken Andre
    Planchard, David
    Adam, Julien
    Soria, Jean-Charles
    BULLETIN DU CANCER, 2011, 98 (03) : 305 - 321
  • [47] Immunotherapy in non-small cell lung cancer: rationale, recent advances and future perspectives
    Luo, Wenxin
    Wang, Zhoufeng
    Zhang, Ting
    Yang, Lan
    Xian, Jinghong
    Li, Yalun
    Li, Weimin
    PRECISION CLINICAL MEDICINE, 2021, 4 (04) : 258 - 270
  • [48] Immunotherapy in the treatment of non-small cell lung cancer
    Sundar, Raghav
    Soong, Richie
    Cho, Byoung-Chul
    Brahmer, Julie R.
    Soo, Ross A.
    LUNG CANCER, 2014, 85 (02) : 101 - 109
  • [49] Progress on neoadjuvant immunotherapy in resectable non-small cell lung cancer and potential biomarkers
    Wu, Xinyu
    Chau, Yi Fung
    Bai, Hua
    Zhuang, Xiaofei
    Wang, Jie
    Duan, Jianchun
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [50] EGFR TKI combination with immunotherapy in non-small cell lung cancer
    Ahn, Myung-Ju
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (04) : 465 - 469
12345